Skip to content

CHEMBIO DIAGNOSTICS, INC.: 10-K filed 2018-03-08

What CHEMBIO DIAGNOSTICS, INC. reported in its annual report filed 2018-03-08 (fiscal FY 2017): 45 published measures, 149 facts as tagged in accession 0001092662-18-000013.

This filing

Form
10-K (annual report)
Filed
2018-03-08
Fiscal period
fiscal FY 2017
Accession
0001092662-18-000013 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHEMBIO DIAGNOSTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-12-3116,616,021USD
At 2016-12-3120,575,236USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-12-313,536,825USD
At 2016-12-313,405,650USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-12-3113,079,196USD
At 2016-12-3117,169,586USD
At 2015-12-3117,661,506USD
At 2014-12-3119,724,162USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-12-313,790,302USD
At 2016-12-3110,554,464USD
At 2015-12-315,376,931USD
At 2014-12-314,614,538USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-6,371,760USD365
2016-01-01 to 2016-12-31-13,347,047USD366
2015-01-01 to 2015-12-31-2,397,042USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-5,034,515USD365
2016-01-01 to 2016-12-31-6,704,734USD366
2015-01-01 to 2015-12-311,792,978USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-01-01 to 2017-12-311,026,954USD365
2016-01-01 to 2016-12-31118,706USD366
2015-01-01 to 2015-12-31480,585USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-12-31134,280USD365
2016-01-01 to 2016-12-3112,550,973USD366
2015-01-01 to 2015-12-310USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-1,876,954USD365
2016-01-01 to 2016-12-31-668,706USD366
2015-01-01 to 2015-12-31-1,030,585USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-12-31-50,044,225USD
At 2016-12-31-43,672,465USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-01-01 to 2017-12-3112,300,031shares365
2016-01-01 to 2016-12-3110,622,331shares366
2015-01-01 to 2015-12-319,626,028shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-01-01 to 2017-12-3112,300,031shares365
2016-01-01 to 2016-12-3110,622,331shares366
2015-01-01 to 2015-12-319,626,028shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-0.16USD/shares92
2017-01-01 to 2017-12-31-0.52USD/shares365
2017-07-01 to 2017-09-30-0.05USD/shares92
2017-04-01 to 2017-06-30-0.18USD/shares91
2017-01-01 to 2017-03-31-0.13USD/shares90
2016-10-01 to 2016-12-31-0.21USD/shares92
2016-01-01 to 2016-12-31-1.26USD/shares366
2016-07-01 to 2016-09-30-0.19USD/shares92
2016-04-01 to 2016-06-30-0.86USD/shares91
2016-01-01 to 2016-03-31-0.03USD/shares91
2015-01-01 to 2015-12-31-0.25USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-0.16USD/shares92
2017-01-01 to 2017-12-31-0.52USD/shares365
2017-07-01 to 2017-09-30-0.05USD/shares92
2017-04-01 to 2017-06-30-0.18USD/shares91
2017-01-01 to 2017-03-31-0.13USD/shares90
2016-10-01 to 2016-12-31-0.21USD/shares92
2016-01-01 to 2016-12-31-1.26USD/shares366
2016-07-01 to 2016-09-30-0.19USD/shares92
2016-04-01 to 2016-06-30-0.86USD/shares91
2016-01-01 to 2016-03-31-0.03USD/shares91
2015-01-01 to 2015-12-31-0.25USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-88,305USD365
2016-01-01 to 2016-12-315,800,818USD366
2015-01-01 to 2015-12-31-1,160,243USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-12-311,909,232USD
At 2016-12-311,709,321USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-01-01 to 2017-12-31384,897USD365
2016-01-01 to 2016-12-31304,154USD366
2015-01-01 to 2015-12-31334,386USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-6,482,550USD365
2016-01-01 to 2016-12-31-7,571,777USD366
2015-01-01 to 2015-12-31-3,554,047USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-12-3110,853,643USD
At 2016-12-3118,113,526USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-01-01 to 2017-12-312,945USD365
2016-01-01 to 2016-12-310USD366
2015-01-01 to 2015-12-31836USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-12-313,096,303USD
At 2016-12-313,405,650USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2017-12-311,666,610USD
At 2016-12-310USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2017-12-311,597,377USD
At 2016-12-310USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-12-312,085,340USD
At 2016-12-313,383,729USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-01-01 to 2017-12-3130,497,977USD365
2016-01-01 to 2016-12-3125,440,618USD366
2015-01-01 to 2015-12-3127,809,532USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-12-314,423,618USD
At 2016-12-313,335,188USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-10-01 to 2017-12-311,435,896USD92
2017-07-01 to 2017-09-302,067,934USD92
2017-04-01 to 2017-06-30689,099USD91
2017-01-01 to 2017-03-312,208,212USD90
2016-10-01 to 2016-12-31725,428USD92
2016-07-01 to 2016-09-30707,733USD92
2016-04-01 to 2016-06-30347,972USD91
2016-01-01 to 2016-03-312,481,468USD91

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2017-01-01 to 2017-12-319,021,439USD365
2016-01-01 to 2016-12-317,595,559USD366
2015-01-01 to 2015-12-317,663,035USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-01-01 to 2017-12-318,555,381USD365
2016-01-01 to 2016-12-318,427,554USD366
2015-01-01 to 2015-12-316,377,839USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-12-3112,318,570shares
At 2016-12-3112,026,847shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-12-3162,821,288USD
At 2016-12-3160,721,783USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-12-317,714,032USD
At 2016-12-316,756,125USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-12-315,804,800USD
At 2016-12-315,046,804USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-12-31554,383USD
At 2016-12-31840,145USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-6,460,065USD365
2016-01-01 to 2016-12-31-7,546,229USD366
2015-01-01 to 2015-12-31-3,557,285USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-6,192,812USD365
2016-01-01 to 2016-12-31-13,347,047USD366
2015-01-01 to 2015-12-31-2,397,042USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2017-10-01 to 2017-12-31-1,998,432USD92
2017-07-01 to 2017-09-30-584,661USD92
2017-04-01 to 2017-06-30-2,173,093USD91
2017-01-01 to 2017-03-31-1,615,574USD90
2016-10-01 to 2016-12-31-2,557,757USD92
2016-07-01 to 2016-09-30-2,138,218USD92
2016-04-01 to 2016-06-30-8,347,482USD91
2016-01-01 to 2016-03-31-303,590USD91

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-01-01 to 2017-12-31727,563USD365
2016-01-01 to 2016-12-31782,711USD366
2015-01-01 to 2015-12-31893,305USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-01-01 to 2017-12-311,276,963USD365
2016-01-01 to 2016-12-311,139,228USD366
2015-01-01 to 2015-12-311,372,563USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2017-01-01 to 2017-12-3122,485USD365
2016-01-01 to 2016-12-3125,548USD366
2015-01-01 to 2015-12-31-3,238USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-88,305USD365
2016-01-01 to 2016-12-310USD366
2015-01-01 to 2015-12-3110,726USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2017-01-01 to 2017-12-310USD365
2016-01-01 to 2016-12-315,800,818USD366
2015-01-01 to 2015-12-31-1,170,969USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2017-01-01 to 2017-12-310USD365
2016-01-01 to 2016-12-3112,493,398USD366
2016-08-01 to 2016-08-3112,493,398USD31
2015-01-01 to 2015-12-310USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-12-31-1,298,389USD365
2016-01-01 to 2016-12-31960,758USD366
2015-01-01 to 2015-12-31-5,915,918USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-12-311,088,430USD365
2016-01-01 to 2016-12-31-242,837USD366
2015-01-01 to 2015-12-31-60,274USD365

Inspect the source

Entity
CHEMBIO DIAGNOSTICS, INC. / CIK 0001092662
Captured
SEC response SHA-256
f4e40937d0d95fb11dba8f52939536a64af75af5fd3640d428deb7a120351716

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001092662.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))